CAIHL read · Jun 12, 2026
Healthcare AI's Next Phase: Turning Predictions Into Clinical Action
Framework
What CAIHL does
Critical AI Health Literacy (CAIHL) is an analytical lens — Hugo Campos and Liz Salmi's 2025 National Academy of Medicine commentary, "Critical AI Health Literacy as Liberation Technology." It applies Paulo Freire's theory of critical literacy to health AI.
The central question CAIHL asks is whose interests does this AI actually serve? Four dimensions answer it: who is the primary user, where is it hosted, whose interests does it advance, and does it expand or constrain patient agency.
This deep-read separates the four dimensions on a single item from the day's scan, so you can see the specific structural shape of the AI in question — not just the bucket it landed in.
The four dimensions
How this item reads through CAIHL
Primary user
clinician
Clinicians or care teams are the primary users. Patients are affected downstream.
Hosting
public
Hosted for public use (ChatGPT, Claude, consumer apps). Anyone with a device can use it.
Interests
commercial
Prioritizes vendor or platform commercial interests (advertising, data, retention).
Agency
neutral
Neither clearly expanding nor constraining patient agency.
Editor's CAIHL read
One-sentence synthesis
Trade-press framing of the prediction-to-action transition; agency direction depends entirely on the consent and disclosure layer at the action moment.
In the scan
How this item appeared in the daily scan
Editor's note: Trade-press framing of 'turning predictions into clinical action' is the prediction-to-prescriptive transition the ARPA-H announcement and the OpenAI lawsuit are both downstream of. Different vocabulary, same architecture move.
Summary: HealthTech Magazine: Vendor-trade analysis arguing that the next phase of healthcare AI is the transition from prediction-as-output to clinical-action-as-output — the agentic surface ARPA-H's ADVOCATE program is also operating on.
methodology
Limitations
CAIHL is a lens, not a verdict. The four dimensions are conditions of use — reassess them when a tool's business model, deployment context, or patient behavior changes. See the NAM commentary for the full framework.